Genetic susceptibility to severe immune-related adverse events from immune checkpoint inhibitors

The etiology and pathogenesis of immune-related adverse events (irAEs) remain poorly understood. Progress has been limited by the rarity and heterogeneity of severe irAEs, small cohorts, and underrepresentation of Asian populations. The unpredictability of severe irAEs hinders effective pre-treatment risk stratification. We sought to identify germline genetic determinants of severe irAEs in an Asian cohort of cancer patients. We prospectively recruited 505 cancer patients of Asian ancestry treated with immune checkpoint inhibitors (ICIs) across two tertiary institutions in Singapore. Patients experiencing lower-grade irAEs (Grades 1–2) were excluded from the association analysis to enable a direct comparison between severe cases and unaffected controls. Of 330 patients comparing Cases (NCI-CTCAEv5 ≥ Grade 3 IrAE) and Controls (without irAE), a multi-ethnic pharmacogenomic genome-wide association study (GWAS) was performed across more than 18 cancer subtypes. To complement the agnostic GWAS, an exploratory candidate gene analysis was also performed. LINC01192 rs146525069 was identified as a candidate variant associated with severe irAEs (allele frequency 10.91% in Cases vs 0.73% in Controls, P = 3.51 × 10 −8 , OR = 24.81 (6.92–88.92)). Exploratory candidate gene analysis revealed four polymorphic variants in genes linked to inflammatory and autoimmune diseases: TNF rs1800629 ( P = 0.0044; OR = 2.48; 95% CI = 1.36–4.52), PTPN2 rs1893217 ( P = 0.0117; OR = 1.79; 95% CI = 1.15–2.79), PTPN2 rs2542151 ( P = 0.0195; OR = 1.71; 95% CI = 1.10–2.67) and ROBO1 rs162263 ( P = 0.0480; OR = 0.56; 95% CI = 0.30–1.03). This is the first pharmacogenomic study of high-grade irAEs in an Asian population, identifying LINC01192 as a variant associated with severe irAEs. Our findings also highlight shared immune regulatory pathways between irAEs and autoimmune diseases, supporting the development of germline-based risk stratification to personalize ICI therapy.

Authors

Institutions

Publication Details

Journal
Cancer Immunology Immunotherapy
Published
2026-11-18
DOI
https://doi.org/10.1007/s00262-026-04640-4
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Genetic susceptibility to severe immune-related adverse events from immune checkpoint inhibitors

Adrian Chin-Leong Kee, Eng Soo Yap, Manjari Lahiri, Anand Devaprasath D. Jeyasekharan et al.
Cancer Immunology Immunotherapy
Cancer Immunotherapy and Biomarkers
article

Genetic susceptibility to severe immune-related adverse events from immune checkpoint inhibitors

Adrian Chin-Leong Kee, Eng Soo Yap, Manjari Lahiri, Anand Devaprasath D. Jeyasekharan, Li Ren Kong, Wei Sheng Edwin Thong, Yu Yang Soon, Sen Hee Tay, Ross Andrew Soo, Alvin Seng Cheong Wong, Boon Cher Goh, Mamta Ruparel, Valencia Lim, Mark Dhinesh Muthiah, May Shuen Tang, Folefac Aminkeng, Amy M.L. Quek, Esther Hian Li Chan, Lavina D. Bharwani, Yiqing Huang, Thuya Win Lwin, Chris Lixian Tan, Margaret Li Peng Teng, Joan R.E. Choo, Yvonne L.E. Ang, Li‐Ling Tan, Ming Yee Sim, Yi Da, Samantha Peiling Yang, Joseph J. Zhao, Chieh Yang Koo, Soo Chin Lee, Jonathan Lee, Lingzhi Wang, Kay W. P. Ng
article en

Abstract

The etiology and pathogenesis of immune-related adverse events (irAEs) remain poorly understood. Progress has been limited by the rarity and heterogeneity of severe irAEs, small cohorts, and underrepresentation of Asian populations. The unpredictability of severe irAEs hinders effective pre-treatment risk stratification. We sought to identify germline genetic determinants of severe irAEs in an Asian cohort of cancer patients. We prospectively recruited 505 cancer patients of Asian ancestry treated with immune checkpoint inhibitors (ICIs) across two tertiary institutions in Singapore. Patients experiencing lower-grade irAEs (Grades 1–2) were excluded from the association analysis to enable a direct comparison between severe cases and unaffected controls. Of 330 patients comparing Cases (NCI-CTCAEv5 ≥ Grade 3 IrAE) and Controls (without irAE), a multi-ethnic pharmacogenomic genome-wide association study (GWAS) was performed across more than 18 cancer subtypes. To complement the agnostic GWAS, an exploratory candidate gene analysis was also performed. LINC01192 rs146525069 was identified as a candidate variant associated with severe irAEs (allele frequency 10.91% in Cases vs 0.73% in Controls, P = 3.51 × 10 −8 , OR = 24.81 (6.92–88.92)). Exploratory candidate gene analysis revealed four polymorphic variants in genes linked to inflammatory and autoimmune diseases: TNF rs1800629 ( P = 0.0044; OR = 2.48; 95% CI = 1.36–4.52), PTPN2 rs1893217 ( P = 0.0117; OR = 1.79; 95% CI = 1.15–2.79), PTPN2 rs2542151 ( P = 0.0195; OR = 1.71; 95% CI = 1.10–2.67) and ROBO1 rs162263 ( P = 0.0480; OR = 0.56; 95% CI = 0.30–1.03). This is the first pharmacogenomic study of high-grade irAEs in an Asian population, identifying LINC01192 as a variant associated with severe irAEs. Our findings also highlight shared immune regulatory pathways between irAEs and autoimmune diseases, supporting the development of germline-based risk stratification to personalize ICI therapy.

Cancer Immunology Immunotherapy
National University of Singapore (SG), Nanyang Technological University (SG), Medical College of Wisconsin (US), Tan Tock Seng Hospital (SG), National University Cancer Institute, Singapore (SG), National University Heart Centre Singapore (SG), National University Hospital (SG), National Heart Centre Singapore (SG), National University Health System (SG), Cancer Science Institute of Singapore (SG)
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon